Carbamazepine will decrease the extent or effect of pirfenidone by impacting hepatic enzyme CYP1A2 metabolism. Contraindicated. Usage of sturdy CYP1A2 inducers ought to be discontinued in advance of initiating pirfenidone and avoided through remedy Usage of sturdy CYP1A2 inhibitors needs to be discontinued prior to initiating therapy and prevented in https://gastong444sdo7.anchor-blog.com/profile